Trials360 Developed Stroke Rat Model

Description:

Greetings from the Trials 360 monthly newsletter!

We are thrilled to announce another milestone at Trials 360:

The successful development of a Stroke Rat Model through Common Carotid Artery Occlusion (CCAO).

This achievement holds significant importance in medical research, particularly in the study of Ischemic Stroke, a major global health concern. Having a reliable animal model for Ischemic Stroke will greatly enhance our understanding of its mechanisms and potential therapeutic interventions.

Trials 360 leads in preclinical and clinical trials, showcasing expertise in innovative stroke rat models through CCAO. Our comprehensive services extend beyond stroke, offering tailored solutions for a spectrum of disease models (such as vascular dementia, cognitive impairment, or other neurological deficits that may result from stroke or be related to the underlying mechanisms of stroke) to advance your research.

We are also excited to share that Trials 360 has previously developed a respiratory inflammation model, demonstrating our expertise in this area as well. With proof-of-concept studies in both inflammatory and stroke models, we are well-equipped to provide comprehensive services in these domains.

This milestone further solidifies our commitment to advancing medical research and providing innovative solutions for a wide range of conditions

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top

Dr. Fatima Tariq,

Business Development Officer

Dr. Fatima Tariq, Pharm.D is a pharmacy professional with experience across the retail, hospital, and pharmaceutical sectors. She earned her Doctor of Pharmacy degree from Akhtar Saeed College of Pharmaceutical Sciences, affiliated with the University of the Punjab.

She began her career as an IPD Pharmacist at Hameed Latif Hospital and later transitioned into business development within the pharmaceutical industry. Currently, she serves as a Business Development Officer at Trial 360.

Her expertise includes business development strategies, client relationship management, market research, competitive analysis, stakeholder engagement, and identifying growth opportunities. Combining pharmaceutical knowledge with commercial insight, she is committed to fostering strategic partnerships and driving sustainable business growth within the healthcare and clinical research landscape.